SCHEMBL23697270

SCHEMBL23697270

Brc1ccc2c(c1)C(c1ccccc1)(c1ccccc1)c1cc(-c3ccccc3)ccc1S2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.41
ALDH1A1 P00352 2/20 0.41
SLC27A2 O14975 1/20 0.33
ADAMTS5 Q9UNA0 1/20 0.33
DRD2 P14416 1/20 0.33
MCL1 Q07820 1/20 0.33
NPC1 O15118 1/20 0.33
NFKB1 P19838 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
GABRA1 P14867 2/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
AGTR1 P30556 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16787352 0.86 OPRM1 (0.37) SLC27A2ADAMTS5SMN1; SMN2OPRM1OPRD1
SCHEMBL23696825 0.85 PDK2 (0.41) MAPK1ALDH1A1SLC27A2ADAMTS5OPRM1
SCHEMBL16922981 0.83 MAPK1 (0.45) MAPK1ALDH1A1MCL1NPC1NFKB1
SCHEMBL15678833 0.80 MAPK1 (0.42) MAPK1ALDH1A1MCL1NPC1NFKB1
SCHEMBL12781938 0.80 MAPK1 (0.45) MAPK1ALDH1A1MCL1NPC1NFKB1
SCHEMBL16922978 0.80 MAPK1 (0.45) MAPK1ALDH1A1MCL1NPC1NFKB1
SCHEMBL23697268 0.78 NOX1 (0.38) OPRM1OPRD1PDK2
SCHEMBL25705121 0.78 ALDH1A1 (0.33) MAPK1ALDH1A1NPC1RAB9AOPRM1
SCHEMBL21743387 0.78 MEN1 (0.40) MAPK1ALDH1A1DRD2NPC1NFKB1
SCHEMBL21743631 0.78 MEN1 (0.40) MAPK1ALDH1A1DRD2NPC1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
WO-2021149998-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME 덕산네오룩스 주식회사 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME ORAI2, OR10J3, OR51E2 MAPK1 3142/4885ALDH1A1 2208/4885SLC27A2 3504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.